The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

Jacques Hébert, Michael Blaiss, Susan Waserman, Harold Kim, Peter Socrates Creticos, Jennifer Maloney, Amarjot Kaur, Ziliang Li, Harold Nelson, Hendrik Nolte

Research output: Contribution to journalArticle

Abstract

Background: The effect of sublingual Timothy grass immunotherapy tablet 2800 BAU (grass SLIT-T) has been evaluated in three North American trials in adults and children who have allergic rhinitis with or without conjunctivitis (AR/C). This paper examines the effects of grass SLIT-T in Canadians. Methods: Data for grass-allergic Canadians in three randomized, placebo-controlled, double-blind trials were analyzed post hoc: 1) adults ≥18 y, grass-pollen season [GPS] 2009; 2) children 5-

Original languageEnglish (US)
Article number53
JournalAllergy, Asthma and Clinical Immunology
Volume10
Issue number1
DOIs
StatePublished - Oct 30 2014

Fingerprint

Phleum
Sublingual Immunotherapy
Poaceae
Tablets
Hypersensitivity
Safety
Conjunctivitis
Pollen
Immunotherapy
Placebos

Keywords

  • Allergic rhinitis
  • Conjunctivitis
  • Sublingual immunotherapy tablet
  • Timothy grass pollen

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. / Hébert, Jacques; Blaiss, Michael; Waserman, Susan; Kim, Harold; Creticos, Peter Socrates; Maloney, Jennifer; Kaur, Amarjot; Li, Ziliang; Nelson, Harold; Nolte, Hendrik.

In: Allergy, Asthma and Clinical Immunology, Vol. 10, No. 1, 53, 30.10.2014.

Research output: Contribution to journalArticle

Hébert, Jacques ; Blaiss, Michael ; Waserman, Susan ; Kim, Harold ; Creticos, Peter Socrates ; Maloney, Jennifer ; Kaur, Amarjot ; Li, Ziliang ; Nelson, Harold ; Nolte, Hendrik. / The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. In: Allergy, Asthma and Clinical Immunology. 2014 ; Vol. 10, No. 1.
@article{bd30e775dfc74514870d235cc4bb2270,
title = "The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children",
abstract = "Background: The effect of sublingual Timothy grass immunotherapy tablet 2800 BAU (grass SLIT-T) has been evaluated in three North American trials in adults and children who have allergic rhinitis with or without conjunctivitis (AR/C). This paper examines the effects of grass SLIT-T in Canadians. Methods: Data for grass-allergic Canadians in three randomized, placebo-controlled, double-blind trials were analyzed post hoc: 1) adults ≥18 y, grass-pollen season [GPS] 2009; 2) children 5-",
keywords = "Allergic rhinitis, Conjunctivitis, Sublingual immunotherapy tablet, Timothy grass pollen",
author = "Jacques H{\'e}bert and Michael Blaiss and Susan Waserman and Harold Kim and Creticos, {Peter Socrates} and Jennifer Maloney and Amarjot Kaur and Ziliang Li and Harold Nelson and Hendrik Nolte",
year = "2014",
month = "10",
day = "30",
doi = "10.1186/1710-1492-10-53",
language = "English (US)",
volume = "10",
journal = "Allergy, Asthma and Clinical Immunology",
issn = "1710-1484",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

AU - Hébert, Jacques

AU - Blaiss, Michael

AU - Waserman, Susan

AU - Kim, Harold

AU - Creticos, Peter Socrates

AU - Maloney, Jennifer

AU - Kaur, Amarjot

AU - Li, Ziliang

AU - Nelson, Harold

AU - Nolte, Hendrik

PY - 2014/10/30

Y1 - 2014/10/30

N2 - Background: The effect of sublingual Timothy grass immunotherapy tablet 2800 BAU (grass SLIT-T) has been evaluated in three North American trials in adults and children who have allergic rhinitis with or without conjunctivitis (AR/C). This paper examines the effects of grass SLIT-T in Canadians. Methods: Data for grass-allergic Canadians in three randomized, placebo-controlled, double-blind trials were analyzed post hoc: 1) adults ≥18 y, grass-pollen season [GPS] 2009; 2) children 5-

AB - Background: The effect of sublingual Timothy grass immunotherapy tablet 2800 BAU (grass SLIT-T) has been evaluated in three North American trials in adults and children who have allergic rhinitis with or without conjunctivitis (AR/C). This paper examines the effects of grass SLIT-T in Canadians. Methods: Data for grass-allergic Canadians in three randomized, placebo-controlled, double-blind trials were analyzed post hoc: 1) adults ≥18 y, grass-pollen season [GPS] 2009; 2) children 5-

KW - Allergic rhinitis

KW - Conjunctivitis

KW - Sublingual immunotherapy tablet

KW - Timothy grass pollen

UR - http://www.scopus.com/inward/record.url?scp=84920768981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920768981&partnerID=8YFLogxK

U2 - 10.1186/1710-1492-10-53

DO - 10.1186/1710-1492-10-53

M3 - Article

C2 - 25685162

AN - SCOPUS:84920768981

VL - 10

JO - Allergy, Asthma and Clinical Immunology

JF - Allergy, Asthma and Clinical Immunology

SN - 1710-1484

IS - 1

M1 - 53

ER -